3-Phenylpiperidine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
3-Phenylpiperidine is a chemical compound and cyclized phenethylamine.[1] It can be thought of as β-phenethylamine with a propyl group connecting the amine and the β position.[1]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.021.458 |
| Chemical and physical data | |
| Formula | C11H15N |
| Molar mass | 161.248 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Daniel Trachsel and colleagues in 2013, the pharmacology of 3-phenylpiperidine itself has not been reported, only its chemical synthesis has been described.[1][2] 3-Phenylpiperidine was first described in the scientific literature by 1933.[1][2]
Derivatives
3-Phenylpiperidine is a parent compound of several drugs such as the psychedelic and related drugs LPH-5 ((S)-2C-TFM-3PIP),[3] 2C-B-3PIP, 2C-B-3PIP-NBOMe, 2C-B-3PIP-POMe, 2T-2CTFM-3PIP, and Z3517967757 (Z7757),[4] the antipsychotic OSU-6162,[5] and the sigma receptor agonist 3-PPP.[1]
- 3-Phenylpiperidine
- Preclamol ((–)-3-PPP)
- OSU-6162 (PNU-96391)
- LPH-5 ((S)-2C-TFM-3PIP)
- Z3517967757 (Z7757)